Scientific prerequisites and prospects for the use of sildenafil in patients with COVID-19


DOI: https://dx.doi.org/10.18565/pharmateca.2021.2.12-14

V.M. Tsvetov (1), A.V. Matveev (2)

1) Federal Center for Cardiovascular Surgery, Chelyabinsk, Russia, https://orcid.org/0000-0003-4810-2295; 2) Russian Medical Academy of Continuous Professional Education, Moscow, Russia, https://orcid.org/0000-0002-6636-3950
Currently, there are only theoretical prerequisites for using the sildenafil to treat patients with COVID-19. There is no clinical evidence to recommend the use of this drug in real clinical practice to prevent and alleviate symptoms in patients with COVID-19. The use of sildenafil in the treatment of a new coronavirus infection is possible only within the framework of clinical trials.
Keywords: COVID-19, sildenafil

Бионика Медиа